Sramana Mitra: What role did you play in this company? There were other people who co-founded the company and you came in later? John Rauscher: Yes, I came in as the COO. Then, I became the CEO of the company. Sramana Mitra: When the company was sold to Oracle, you were running the company? John
John has self-financed and scaled an interesting AI software company built on French technology, and would like to take it public. Very impressive execution! Sramana Mitra: Let’s start at the very beginning of your journey. Where are you from? Where were you born and raised? What kind of background? John Rauscher: I was born and
Continuing on our theme of ‘Bootstrap First, Raise Money Later’, here’s William King’s story of building a robust company in the healthcare industry, now funded by Kleiner Perkins. Sramana Mitra: Let’s start at the very beginning of your story. Where are you from? Where were you born, raised, and in what kind of circumstances? William
Sramana Mitra: Fascinating. Other than the 50% of revenue coming from financial services, are there any other dominant sectors? Obviously, media continues to be one? Stuart Frankel: We continue to do a little bit in media. Our business with the US intelligence community is a fair chunk of our business today. We also have customers in
Sramana Mitra: Does that mean that you can charge higher rates for the leads? Are you even able to take a transaction commission? What does that give you in terms of financial metrics? Avi Steinlauf: All of the above. It allows us to work much more closely with our partners, and depending on the individual
Sramana Mitra: Do they pay a subscription? Stuart Frankel: Yes. I’ll tell you how much the business has evolved. Given our customers today and given what we do, it’s a much more relevant model for us rather than selling volumes of content. When we were creating news content, that’s how news content is bought. That’s
Sramana Mitra: Did you have venture capitalists in your early rounds? Avi Steinlauf: There were some small venture funds that were portions of larger companies but none of the blue chip VC funds that you would be familiar with today. Sramana Mitra: When you were raising money at that time, was this part of the
Sramana Mitra: How does it work? Can you explain the science behind it? Stuart Frankel: We would have to fast forward a little bit as well, because at that time this was a baseball story writer. That’s the prototype that was built in the lab. It worked really well but all it did was write